Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO

NCT03815890 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Nivolumab
DRUG: Ipilimumab
DRUG: Ipilimumab

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]